Jeanne Harvey

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 7 EPO patents. Top assignees: Nestec S.a., Prometheus Laboratories Inc., Societe Des Produits Nestle S.a.. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeanne Harvey. Retrieved from https://idiyas.com/inventor/jeanne-harvey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 100(Granted Patents)

Company Filing History:

Prometheus Laboratories Inc.

patents

2 out of 1,287

Societe Des Produits Nestle S.a.

patents

Years Active: 2011-2020

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10527622 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2020-01-07),

2. 10436786 - Methods for detecting truncated receptors using antibody-based arrays (2019-10-08),

3. 9575066 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2017-02-21),

4. 9285369 - Antibody-based arrays for detecting multiple signal transducers in rare circulating cells (2016-03-15),

5. 9274116 - Drug selection for breast cancer therapy using antibody-based arrays (2016-03-01),

6. 9250243 - Drug selection for lung cancer therapy using antibody-based arrays (2016-02-02),

7. 8658388 - Antibody-based arrays for detecting multiple signal transducers in rate circulating cells (2014-02-25),

8. 8609349 - Drug selection for breast cancer therapy using antibody-based arrays (2013-12-17),

9. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays (2012-04-24),

10. 7908091 - Methods of predicting and monitoring tyrosine kinase inhibitor therapy (2011-03-15),

Title: The Innovative Contributions of Jeanne Harvey

Introduction

Jeanne Harvey is a prominent inventor based in Livermore, California, known for her significant contributions to the field of cancer diagnostics and treatment. With a total of 10 patents to her name, she has developed groundbreaking technologies that enhance the understanding and treatment of cancer.

Latest Patents

Among her latest patents is the invention of antibody-based arrays for detecting multiple signal transducers in rare circulating cells. This invention provides a method for detecting the activation state and total amount of various signal transduction molecules in rare circulating cells, facilitating cancer prognosis and diagnosis, as well as the design of personalized, targeted therapies. Another notable patent involves methods for detecting truncated receptors using antibody-based arrays. This invention offers compositions and methods for assessing the activation states of components of signal transduction pathways in tumor cells, which can be crucial for cancer diagnosis, prognosis, and treatment design.

Career Highlights

Throughout her career, Jeanne has worked with notable companies such as Nestec S.A. and Prometheus Laboratories Inc. Her work has significantly impacted the field of cancer research and treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Jeanne has collaborated with esteemed colleagues, including Sharat Singh and Phillip Kim, further enhancing her innovative work in the field.

Conclusion

Jeanne Harvey's contributions to cancer diagnostics and treatment through her innovative patents and collaborations highlight her as a leading figure in the field. Her work continues to pave the way for advancements in personalized medicine and cancer therapies.

Profile summary based on public USPTO records.